ImportRefusal LogoImportRefusal

Emd Serono Canada

⚠️ Moderate Risk

FEI: 3007371071 • Edmonton, ALBERTA • CANADA

FEI

FEI Number

3007371071

📍

Location

Edmonton, ALBERTA

🇨🇦

Country

CANADA
🏢

Address

2011 94 Street N, , Edmonton, ALBERTA, Canada

Moderate Risk

FDA Import Risk Assessment

47.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
3
Unique Violations
8/30/2012
Latest Refusal
8/30/2012
Earliest Refusal

Score Breakdown

Violation Severity
88.8×40%
Refusal Volume
25.9×30%
Recency
0.0×20%
Frequency
40.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

714×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

1863×

INSANITARY

The article is subject to refusal of admission pursuant to section 801(a)(3) in that the article appears to have been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

Refusal History

DateProductViolationsDivision
8/30/2012
57YL99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
186INSANITARY
71NO LICENSE
New Orleans District Office (NOL-DO)
8/30/2012
57YL99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
186INSANITARY
71NO LICENSE
New Orleans District Office (NOL-DO)
8/30/2012
57YL99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
186INSANITARY
71NO LICENSE
New Orleans District Office (NOL-DO)
8/30/2012
57YL99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C.
27DRUG GMPS
71NO LICENSE
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Emd Serono Canada's FDA import refusal history?

Emd Serono Canada (FEI: 3007371071) has 4 FDA import refusal record(s) in our database, spanning from 8/30/2012 to 8/30/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Emd Serono Canada's FEI number is 3007371071.

What types of violations has Emd Serono Canada received?

Emd Serono Canada has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Emd Serono Canada come from?

All FDA import refusal data for Emd Serono Canada is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.